Cargando…

Change in HbA(1c) Across the Baseline HbA(1c) Range in Type 2 Diabetes Patients Receiving Once-Weekly Dulaglutide Versus Other Incretin Agents

INTRODUCTION: This exploratory post hoc analysis investigated the relative changes in glycated haemoglobin (HbA(1c)) in patients with type 2 diabetes mellitus (T2DM) treated with dulaglutide versus active comparators across a continuous range of baseline HbA(1c) values using data from three phase II...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gentilella, Raffaella, Romera, Irene, Nicolay, Claudia, Buzzetti, Raffaella, Vázquez, Luis Alberto, Sesti, Giorgio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6531505/ https://www.ncbi.nlm.nih.gov/pubmed/31055780 http://dx.doi.org/10.1007/s13300-019-0625-3

Ejemplares similares

Effect of once‐weekly dulaglutide on glycated haemoglobin (HbA1c) and fasting blood glucose in patient subpopulations by gender, duration of diabetes and baseline HbA1c
por: Gallwitz, Baptist, et al.
Publicado: (2017)

Efficacy and safety outcomes of dulaglutide by baseline HbA1c: A post hoc analysis of the REWIND trial
por: Franek, Edward, et al.
Publicado: (2022)

Cost of Achieving HbA1c Treatment Targets and Weight Loss Responses with Once-Weekly Semaglutide Versus Dulaglutide in the United States
por: Wilkinson, Lars, et al.
Publicado: (2018)

Measurement of HbA(1c) and HbA(2) by Capillarys 2 Flex Piercing HbA(1c) programme for simultaneous management of diabetes and screening for thalassemia
por: Ke, Peifeng, et al.
Publicado: (2017)

HbA(1c): The lower the better?
por: Araki, Eiichi, et al.
Publicado: (2011)

The True Value of HbA1c as a Predictor of Diabetic Complications: Simulations of HbA1c Variables
por: Lind, Marcus, et al.
Publicado: (2009)

Haemoglobin J-Baltimore can be detected by HbA(1c) electropherogram but with underestimated HbA(1c) value
por: Brunel, Valéry, et al.
Publicado: (2016)

Hemoglobin variants detected by hemoglobin A1c (HbA1c) analysis and the effects on HbA1c measurements
por: Nasir, Nadzimah Mohd, et al.
Publicado: (2010)

Efficacy and Safety of Dulaglutide by Baseline HbA1c in Chinese Patients with Type 2 Diabetes: A Post Hoc Analysis
por: Yu, Miao, et al.
Publicado: (2020)

Influence of Serum Albumin on HbA1c and HbA1c-Defined Glycemic Status: A Retrospective Study
por: Feng, Xiaojing, et al.
Publicado: (2021)

Drugs affecting HbA1c levels
por: Unnikrishnan, Ranjit, et al.
Publicado: (2012)

Current Status of HbA1c Biosensors
por: Lin, Hua, et al.
Publicado: (2017)

In-House Algorithm for Reporting Discrepant HbA1c Result and Troubleshooting a Case of False Low HbA1c
por: Pant, Vivek, et al.
Publicado: (2021)

Estimation of mean erythrocyte age using HbA1c or HbA1c/glycated albumin for evaluation of anemia severity
por: Koga, Masafumi, et al.
Publicado: (2023)

Glycaemic efficacy of an expanded dose range of dulaglutide according to baseline glycated haemoglobin (HbA1c) subgroup: Post hoc analysis of AWARD‐11
por: Frias, Juan P., et al.
Publicado: (2021)

Should Studies of Diabetes Treatment Stratification Correct for Baseline HbA1c?
por: Jones, Angus G., et al.
Publicado: (2016)

Association of visit-to-visit HbA1c variability with cardiovascular diseases in type 2 diabetes within or outside the target range of HbA1c
por: Sun, Bao, et al.
Publicado: (2022)

Hb H Interference on Measurement Of HbA1c With Ion-Exchange HPLC
por: Agilli, Mehmet, et al.
Publicado: (2013)

HbA(1c) measurement and relationship to incident stroke
por: Robson, R., et al.
Publicado: (2016)

Very low HbA1C, is it a problem?
por: Joob, Beuy, et al.
Publicado: (2018)

Visit-to-visit HbA1c variability is inversely related to baroreflex sensitivity independently of HbA1c value in type 2 diabetes
por: Matsutani, Daisuke, et al.
Publicado: (2018)

Significantly High HbA(1c) in Diabetic Patient with Hb J: Case Report
por: Wan Nik, Wan Nor Fazila Hafizan, et al.
Publicado: (2022)

A Relative Cost of Control Analysis of Once-Weekly Semaglutide Versus Exenatide Extended-Release and Dulaglutide for Bringing Patients to HbA1c and Weight Loss Treatment Targets in the USA
por: Johansen, Pierre, et al.
Publicado: (2019)

Influence of Baseline HbA1c and Antiplatelet Therapy on 1-Year Vein Graft Outcome
por: Zhu, Yunpeng, et al.
Publicado: (2022)

An Evaluation of Point-of-Care HbA1c, HbA1c Home Kits, and Glucose Management Indicator: Potential Solutions for Telehealth Glycemic Assessments
por: Zaharieva, Dessi P., et al.
Publicado: (2022)

Correction to: A Relative Cost of Control Analysis of Once-Weekly Semaglutide Versus Exenatide Extended-Release and Dulaglutide for Bringing Patients to HbA1c and Weight Loss Treatment Targets in the USA
por: Johansen, Pierre, et al.
Publicado: (2019)

Association of Diabetes and HbA(1c) Levels With Gastrointestinal Manifestations
por: Tseng, Ping-Huei, et al.
Publicado: (2012)

An Emerging Diabetes Mellitus Diagnosis Modality: HbA(1c)
por: Seo, Hyun-Ae, et al.
Publicado: (2012)

The Utility of HbA1c as a Diagnostic Criterion of Diabetes
por: Kim, Hee-Jung, et al.
Publicado: (2011)

The Importance of HbA1c Control in Patients with Subclinical Hypothyroidism
por: Billic-Komarica, Edina, et al.
Publicado: (2012)

HbA1c: A Review of Analytical and Clinical Aspects
por: Weykamp, Cas
Publicado: (2013)

Report on HbA(1c) Proficiency Testing in Asia in 2012
por: Umemoto, Masao, et al.
Publicado: (2015)

Relationship between level of HbA1C and breast cancer
por: Jousheghany, Fariba, et al.
Publicado: (2016)

Glycated haemoglobin (HbA(1c)) for postmortem diagnosis of diabetes
por: Lepik, Delia, et al.
Publicado: (2018)

HbA1c and retinal sensitivity in diabetics using microperimetry
por: Sharanjeet-Kaur, et al.
Publicado: (2019)

Analytical performance evaluation of the Norudia HbA(1c) assay
por: Lee, Joon Hee, et al.
Publicado: (2020)

Electrokinetic Mixing for Improving the Kinetics of an HbA1c Immunoassay
por: Yasun, Emir, et al.
Publicado: (2019)

HbA1c, Coronary atheroma progression and cardiovascular outcomes
por: Dykun, Iryna, et al.
Publicado: (2022)

HbA1c at term delivery and adverse pregnancy outcome
por: Hong, Jesrine Gek Shan, et al.
Publicado: (2022)

Is HbA1c an ideal biomarker of well-controlled diabetes?
por: Kaiafa, Georgia, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_od4r51tfh0bicc40klkhp38dd0